← Back
Data updated: Mar 10, 2026
ANTHEA PHARMA
CardiovascularMetabolic
ANTHEA PHARMA is a generic drug manufacturer focused on Cardiovascular, Metabolic.
2025
Since
5
Drugs
-
Trials
73
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LACOSAMIDE 2026-01-29
LACOSAMIDE 2026-01-21
SODIUM BICARBONATE 2026-01-13
NOREPINEPHRINE BITARTRATE 2025-12-11
NOREPINEPHRINE BITARTRATE 2025-11-25
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
LACOSAMIDE 2025-10-15
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
1 drugs
Metabolic 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (3)
Company Info
- First Approval
- 2025-03-21
- Latest
- 2026-01-21
- Applications
- 5